BridgeBio Pharma(BBIO)
$78.30+0.13 (+0.17%)
BBIO
BridgeBio Pharma financials statements
$78.30
At close:+0.13 (+0.17%)
Want to see BBIO full AI Analyst Report?
BridgeBio Pharma (BBIO) Income Statement
1,538 Followers
BridgeBio Pharma Income Statement
Last quarter (Q3 2026), BridgeBio Pharma's total revenue was $353.17M, an increase of 192.60% from the same quarter last year. In Q3, BridgeBio Pharma's net income was $-56.71M. See BridgeBio Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 502.08M | $ 221.90M | $ 9.30M | $ 77.65M | $ 69.72M | |
| $ 473.81M | $ 218.02M | $ 6.86M | $ 74.21M | $ 66.60M | |
| $ 1.04B | $ 811.00M | $ 614.23M | $ 586.42M | $ 643.23M | |
| Depreciation and Amortization | $ 5.43M | $ 6.08M | $ 6.49M | $ 6.77M | $ 5.84M |
| $ -676.45M | $ -436.83M | $ -565.47M | $ -397.44M | $ -533.83M | |
| $ -569.09M | $ -592.97M | $ -607.37M | $ -512.20M | $ -576.63M | |
| $ -165.90M | $ 50.78M | $ -45.88M | $ 27.55M | $ -9.82M | |
| $ -734.99M | $ -542.19M | $ -653.25M | $ -484.65M | $ -586.45M | |
| $ -729.31M | $ -535.76M | $ -643.20M | $ -481.18M | $ -562.54M | |
| Per Share Metrics | |||||
| Basic EPS | $ -3.79 | $ -2.88 | $ -3.95 | $ -3.35 | $ -3.90 |
| Diluted EPS | $ -3.79 | $ -2.88 | $ -3.95 | $ -3.35 | $ -3.90 |
| Weighted Average Shares Outstanding | 197.24M | 186.08M | 162.79M | 147.47M | 144.36M |
| Weighted Average Shares Outstanding (Diluted) | 197.24M | 186.08M | 162.79M | 147.47M | 144.36M |
Currency in USD

